Clinical Trials · NCT03375463
A Study of Tirzepatide (LY3298176) in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 52
- Start date
- Dec 2017
- Locations
- 1 site, United States
- Primary endpoint
- Pharmacokinetics (PK) Part A: Area Under the Concentration Versus Time Curve [AUC (0-∞)] of Tirzepatide